Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | ESRRG | P62508 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 2/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4943546 | 0.91 | CYP3A4 (0.54) | ESR1ESR2CYP3A4SMN1; SMN2PDK2 | |
| SCHEMBL17787262 | 0.86 | CYP3A4 (0.50) | ESR1ESR2CYP3A4SMN1; SMN2PDK2 | |
| SCHEMBL225915 | 0.85 | NOS1 (0.50) | CYP3A4SMN1; SMN2ALDH1A1ESRRGNOS1 | |
| SCHEMBL14397685 | 0.84 | ALDH1A1 (0.54) | ESR1ESR2CYP3A4SMN1; SMN2PDK2 | |
| SCHEMBL14397500 | 0.84 | ALDH1A1 (0.54) | ESR1ESR2CYP3A4SMN1; SMN2PDK2 | |
| SCHEMBL17787403 | 0.83 | CYP3A4 (0.51) | ESR1ESR2CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL26290184 | 0.82 | ESR1 (0.50) | ESR1ESR2CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL12214816 | 0.80 | CYP3A4 (0.45) | ESR1ESR2CYP3A4SMN1; SMN2PDK2 | |
| SCHEMBL555384 | 0.79 | ALDH1A1 (0.56) | ALDH1A1RECQLNR1I2 | |
| SCHEMBL6333569 | 0.79 | LTA4H (0.47) | ESR1ESR2SMN1; SMN2PDK2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4055429-A | — | — | None | — | — | JP | disclosed |
| JP-4139213-A | — | — | None | — | — | JP | disclosed |
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| EP-2190812-B1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES CO (US) | 2015-12-02 | — | — | EP | disclosed |
| US-8426490-B2 | Methacrylate based monomers containing a urethane linkage, process for production and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-04-23 | — | — | US | disclosed |
| US-20100197824-A1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2010-08-05 | — | — | US | disclosed |
| EP-2190812-A1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | 3M Innovative Properties Company (US) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009042574-A1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-04-02 | — | — | WO | disclosed |
| EP-2042486-A1 | Methacrylate Based Monomers containing a Urethane Linkage, Process for Production and Use thereof | 3M Innovative Properties Company (US) | 2009-04-01 | — | — | EP | disclosed |
| JP-H04139213-A | FLUORINE-CONTAINING PROPOXYCYCLOHEXYLENE POLYCARBONATE RESIN | CHISSO CORP | 1992-05-13 | — | — | JP | disclosed |
| JP-H0455429-A | PROPYLENEOXYFLUORINE-CONTAINING POLYCARBONATE RESIN | CHISSO CORP | 1992-02-24 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197824-A1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | PYM1, B2M, MACF1 | ESR1 328/4885ESR2 475/4885CYP3A4 808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.